European regulators advanced several new medicines, including a combined flu and COVID vaccine and new treatments for rare diseases.
The orphan drugs market is seeing strong expansion, propelled by the growing worldwide incidence of genetic conditions and other rare diseases, as well as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results